![Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.](https://oncodaily.com/pub/uploads/2024/07/IMG_9859.png)
Jul 4, 2024, 10:04
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, shared a post on X:
“ViPOR in LBCL NEJM by Christopher Melani et al.:
- 20 pts Ph1b / 40 Ph2; RP2D ven 800 mg
- ORR 54% overall: 62% (all CRs!) in non-GC, 67% (CR 53%) in DHL with BCL2
- 2-yr DOCR 78% w/o consolidation, post-CAR 2-yr PFS 30%
Great activity in high-risk R/R subtypes!”
Read further.
Source: Ajay Major/X